Description: Forward Pharma A/S, a biopharmaceutical company, focuses on the provision of dimethyl fumarate (DMF) formulations for the treatment of various immune disorders. It develops FP187, a DMF formulation to treat relapsing remitting multiple sclerosis and psoriasis. The company was founded in 2005 and is headquartered in Copenhagen, Denmark.
Home Page: www.forward-pharma.com
FWP Technical Analysis
Oestergade 24A
Copenhagen,
1100
Denmark
Phone:
45 33 44 42 42
Officers
| Name | Title |
|---|---|
| Mr. Florian Schonharting M.Sc. (Econ) | Co-Founder & Chairman |
| Dr. Claus Bo Søndergaard Svendsen M.D., Ph.D. | Chief Exec. Officer |
| Mr. Thomas Carbone | VP of Fin. & Controller |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.3107 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2014-10-15 |
| Fiscal Year End: | December |
| Full Time Employees: | 4 |